Industry

Additions of Andrew Johnson and Bridget Seay strengthen epocrates’ evolution as a commercial organization with best-in-class market intelligence and products WATERTOWN, Mass.–(BUSINESS WIRE)–epocrates, an athenahealth, Inc. company that delivers digital clinical decision support to prescribers, today announced the expansion of its commercial leadership team to drive the enhancement and development of the company’s commercial product … [Read more…]

Paige and Janssen will collaborate to deploy an AI-powered, H&E-based biomarker test, developed by Janssen, to screen for actionable FGFR2 and FGFR3 genomic alterations within seconds Goal is to provide physicians with important insights to help tailor patients’ treatment plans and facilitate clinical trial recruitment NEW YORK–(BUSINESS WIRE)–Paige, a global leader in clinical AI applications … [Read more…]

Following a successful pilot program in 2021, Hurdle’s tech-enabled, culturally intentional mental health services will be available to more Accolade members in 2022 WASHINGTON–(BUSINESS WIRE)–Hurdle Health, a digital mental health platform for the BIPOC community, today announced an expansion of their pilot with Accolade Health, the first health insurance company built around a full stack … [Read more…]

SUWA, Japan–(BUSINESS WIRE)–Saint-Gobain Life Sciences today announced the addition of their Suwa, Japan manufacturing facility for the production of C-Flex® TPE tubing for use in bioprocessing. The capacity addition in Suwa is part of Saint-Gobain Life Sciences ongoing investment plan to globally expand production capacity for its products and services used throughout the bioprocessing industry. … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Self-injection Devices Market Size, Share & Trends Analysis Report by Product (Autoinjectors, Needle-free Injectors), by Usability (Disposable, Reusable), by Application (Cancer, Pain Management), by Region, and Segment Forecasts, 2022-2030” report has been added to ResearchAndMarkets.com’s offering. The global self-injection devices market size is expected to reach USD 10.8 billion by 2030 and is … [Read more…]

VANCOUVER, British Columbia–(BUSINESS WIRE)–Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating neurodegenerative disorders, today announces that the European Patent Office has confirmed the patentability of EP3009143 in amended form following an opposition … [Read more…]

NEW YORK–(BUSINESS WIRE)–#DCT—Medidata, a Dassault Systèmes company, will be leading an innovative educational workshop on how to master decentralized clinical trials (DCTs), sessions on risk-based monitoring and adaptive designs, and more as a premium sponsor of the DIA (Drug Information Association) Global Annual Meeting, June 19-23. Medidata experts will also be participating in multiple presentations … [Read more…]

Community investments benefit eight organizations throughout Ohio COLUMBUS, Ohio–(BUSINESS WIRE)–Humana Healthy Horizons, the Medicaid business of leading health and well-being company Humana Inc. (NYSE: HUM), announced today that it has invested $4.6 million to support community organizations in Ohio that share the company’s passion for overcoming public health challenges and improving the health and well-being … [Read more…]

CAMBRIDGE, Mass.–(BUSINESS WIRE)–MIT School of Engineering and Northpond Ventures today announced the launch of the MIT-Northpond Program – Advancing Life Science & Engineering Innovation. The five-year engagement is funded through Northpond Labs, the research and development-focused affiliate of Northpond Ventures. The program aims to generate ideas in the life sciences by connecting Northpond’s experienced venture … [Read more…]

BOSTON & SEATTLE & EMERYVILLE, Calif.–(BUSINESS WIRE)–Affini-T Therapeutics, Inc., a biotechnology company unlocking the power of T cells against oncogenic driver mutations, and Metagenomi, Inc., a genetic medicines company with a versatile portfolio of next-generation, wholly-owned gene editing tools, today announced a partnership to enable Affini-T’s next generation ex vivo T cell receptor (TCR) cell … [Read more…]